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Dengue is a mosquito-borne viral infection causing a 
severe flu-like illness and sometimes causing a 
potentially lethal complication called severe dengue.1 
It is caused by the dengue virus (DENV, 1–4 
serotypes) and transmitted by bite of infected Aedes 
aegypti mosquito which bites during daylight hours. 
National Dengue Day is observed in India on May 16 
every year with the recommendation of Ministry of 
Health and Family Welfare, Government of India to 
create awareness about dengue; and to intensify 
preventive measures and preparedness for the control 
of disease in the country before transmission season 
starts.2  
 
A dramatic rise has been seen in the global incidence 
of dengue in recent decades. It is a life-threatening 
infection and results in many deaths each year. About 
half of the world's population is now at risk. There are 
an estimated 100-400 million infections each year.3 
The first epidemic of clinical dengue-like illness was 
recorded in Madras in 1780 and the first virologically 
proved epidemic of dengue fever in India occurred in 
Calcutta and Eastern Coast of India in 1963-1964.4-6 
 
As per the National Vector Borne Disease Control 
Programme (NVBDCP), Ministry of Health & Family 
Welfare, Government of India, 136422 cases and 132 
deaths were reported in India in 2019.7 
 
Aedes aegypti mosquito, also known as the yellow 
fever mosquito, is responsible for spreading dengue 
fever, yellow fever viruses, Zika fever, chikungunya 
and Mayaro.8 These mosquitoes are found worldwide 
(except in Antarctica) and can live in a large and 
eclectic array of ecosystems, from tropical forests to 
urban areas and tundra.9 
 
After an infective bite, the subject develops 
symptoms in 3-14 days which generally a high fever, 
headache, muscle pain, bone and joint pain, nausea, 
vomiting, pain in eyes, rashes and swollen glands. 
Severe dengue or dengue hemorrhagic fever is a life- 
 
 
 
threatening condition with severe abdominal pain, 
persistent vomiting, bleeding gums, bleeding nose, 
hematuria, hematemesis, melena, bleeding under the 
skin, difficulty in breathing, fatigue, restlessness and 
cold-clammy skin. A small proportion of cases may 
show fatal disease as dengue shock syndrome. 
Infected patients become a source of infection and 
can transmit the same to other via Aedes mosquitoes 
during 4-5 days after onset of symptoms.  
 
Children are also too prone as they have a growing 
immune system and are not able to fight the disease 
effectively. Dengue fever not only affects liver and 
leads to a reduction in platelet count but also affects 
kidney, lung, heart and central nervous system. Very 
low levels of platelets can result in internal bleeding 
and shock, which leads to death from multi-organ 
failure. 
 
Virological and serological tests can be used for 
diagnosis of dengue infection. The virological tests 
directly detect elements of the virus and serological 
tests detect human-derived immune components 
that are produced in response to the virus. Patient 
samples collected during the first week of illness 
should be tested by both serological and virological 
methods (RT-PCR). IgM and IgG tests detect dengue 
in the initial stages of infection, but since they throw 
up false positive and false negative results, a 
confirmatory test is needed. A positive IgG but a low 
or negative IgM indicates past dengue infection. The 
NS1 Elisa-based antigen confirmatory test is done 
three days after symptoms appear. 
 
No specific antiviral medication for dengue exists. 
Appropriate and timely clinical diagnosis by 
physician followed by proper clinical management 
helps in reducing the fatality rate. Use of analgesics 
(paracetamol), taking plenty of fluids and rest are 
important aspects of treatment. Precautions should 
be stressed upon and mild dengue might turn into a 
fatal condition. The common precautionary measures  
 
 
 
National Dengue Day (India): Combatting the 
Vector-Borne Public Health Threat 
GUEST COMMENT 
COMMUNICATION 
 
ISSN: 2456-8090 (online) 
DOI: https://doi.org/10.26440/IHRJ/0402.05184 
 Dr. Mandeep Singh 
  QR CODE 
 
 © Mandeep Singh.. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY-NC 4.0, which     
  permits unrestricted use, distribution and reproduction in any medium, provided the use is not commercial and the original author(s) and source are cited.  
26 
International Healthcare Research Journal 2020;4(2):26-27. 
include covering water containers with lids, use of 
larvicidal agents in water storage tanks, use of 
insecticidal sprays in home and surroundings, 
covering arms and legs during transmission season, 
using mosquito nets, insecticide treated bed nets, 
mosquito repellent sprays, creams, lotions, coils and 
vaporizers to prevent mosquito bites, protecting 
dengue patient from further mosquito bites to 
prevent further spread of dengue to other subjects 
and preventing unnecessary stagnation of water. 
 
The prevention and control of dengue depends on 
effective vector control measures. Use of 
acetylsalicylic acid, non-steroidal anti-inflammatory 
drugs and other drugs with effect on blood platelets 
and clotting factors is not recommended. 
Prophylactic platelet transfusions are given in dengue 
fever with thrombocytopenia to prevent hemorrhagic 
complications. Although the use of prophylactic 
platelet transfusions is increasing in countries where 
dengue is endemic, it is associated with risks and has 
financial implications.10 
 
Dengvaxia, a vaccine to prevent dengue, 
manufactured by Sanofi Pasteur, is approved and 
registered in severala countries for specific age group 
and is recommended only to be given to persons with 
confirmed prior dengue virus infection. In 2017, the 
manufacturer announced that the people who receive 
the vaccine and have not been previously infected 
with a dengue virus may be at risk of developing 
severe dengue if they get dengue after being 
vaccinated.11 
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